Ovid Therapeutics Inc (NASDAQ:OVID)
| 2.19 Delayed Data As of Aug 08 |  -0.01 / -0.45%Today’s Change | 1.65 Today|||52-Week Range 4.20 | -31.78% Year-to-Date |
Latest OVID News | Press Releases
No recent news for Ovid Therapeutics Inc.
Today’s Trading
| Previous close | 2.20 |
| Today’s open | 2.21 |
| Day’s range | 2.18 - 2.21 |
| Volume | 625 |
| Average volume (3 months) | 165,498 |
| Market cap | $155.6M |
Data as of 3:59pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -156.04% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,551.57% |
| P/E ratio | NM |
| Price/Sales | 1.05 |
| Price/Book | 0.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRVITrevi Therapeutics I... | +0.36 | +9.21% |
| PDSBPDS Biotechnology Co... | -0.13 | -2.45% |
| CLLSCellectis SA | +0.19 | +5.49% |
| IMUXImmunic Inc | -0.20 | -3.75% |
Data as of 4:00pm ET, 08/08/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $208.4M |
| Annual profit (last year) | $119.8M |
| Net profit margin | 57.51% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
